Champions Oncology, Inc. (CSBR)
| Previous Close | 8.09 |
| Open | 7.89 |
| Bid | 3.20 x 900 |
| Ask | 12.68 x 800 |
| Day's Range | 7.64 - 7.99 |
| 52 Week Range | 6.81 - 11.00 |
| Volume | |
| Avg. Volume | 2,898 |
| Market Cap | 103.254M |
| Beta (5Y Monthly) | 1.03 |
| PE Ratio (TTM) | 382.00 |
| EPS (TTM) | 0.02 |
| Earnings Date | Mar 09, 2022 - Mar 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.67 |
- Simply Wall St.
Investors in Champions Oncology (NASDAQ:CSBR) have made a impressive return of 197% over the past five years
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...
- ACCESSWIRE
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, and Cyclica Inc.
- ACCESSWIRE
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
HACKENSACK, NJ / ACCESSWIRE / May 3, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, announced today that its Lumin Bioinformatics Platform has been selected as a finalist for the ‘Best in Show' Competition at the upcoming Bio-IT World Conference & Expo.
